Five Oceans Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Sell
4,459
-161
-3% -$9.24K 0.08% 166
2026
Q1
$280K Buy
4,620
+725
+19% +$42.3K 0.1% 126
2025
Q4
$210K Buy
+3,895
New +$187K 0.07% 177
2025
Q2
Sell
-4,509
Closed -$275K 191
2025
Q1
$275K Buy
+4,509
New +$263K 0.13% 109
2024
Q4
Sell
-4,097
Closed -$212K 180
2024
Q3
$212K Buy
+4,097
New +$192K 0.1% 174
2024
Q2
Sell
-6,288
Closed -$341K 183
2024
Q1
$341K Buy
6,288
+40
+0.6% +$2.04K 0.18% 103
2023
Q4
$321K Sell
6,248
-1,213
-16% -$63.7K 0.18% 99
2023
Q3
$433K Sell
7,461
-105
-1% -$6.43K 0.28% 74
2023
Q2
$484K Buy
7,566
+1,130
+18% +$75.8K 0.31% 71
2023
Q1
$446K Sell
6,436
-72
-1% -$5.08K 0.29% 77
2022
Q4
$468K Buy
6,508
+90
+1% +$6.79K 0.32% 69
2022
Q3
$456K Buy
6,418
+1,797
+39% +$130K 0.36% 59
2022
Q2
$356K Buy
4,621
+172
+4% +$13.1K 0.27% 75
2022
Q1
$325K Buy
4,449
+191
+4% +$12.8K 0.29% 68
2021
Q4
$265K Sell
4,258
-25
-0.6% -$1.47K 0.23% 85
2021
Q3
$253K Buy
+4,283
New +$282K 0.29% 76

Other funds holding BMY

Five Oceans Advisors's BMY Position: Q2 2026 in Review

Five Oceans Advisors reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2026, selling an estimated $9.24K and leaving 4,459 shares worth $257K. The position accounts for 0.08% of the portfolio, ranked #166.

Five Oceans Advisors first reported a position in BMY in Q3 2021 and has held it in 16 quarters since. The position peaked at $484K in Q2 2023. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Five Oceans Advisors held 4,459 shares of Bristol-Myers Squibb worth $257K as of Q2 2026.
  • Five Oceans Advisors sold 161 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.24K.
  • Bristol-Myers Squibb made up 0.08% of Five Oceans Advisors's portfolio in Q2 2026, its #166 holding.
  • Five Oceans Advisors first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 16 quarters since.
  • Five Oceans Advisors's Bristol-Myers Squibb position peaked at $484K in Q2 2023.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.